European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading

MT Newswires Live07-01 23:12

European equities traded in the US as American depositary receipts were tracking sharply lower late Wednesday morning, falling 1.61% to 1,890.71 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biotech company Evaxion (EVAX), which rose 3% and 2.9% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which were up 2.6% and 2.4% respectively.

The decliners from continental Europe were led by telecommunications company Ericsson (ERIC) and pharmaceutical company Sanofi (SNY), which lost 2.6% and 2.3% respectively. They were followed by oil and gas company Eni (E) and brewing company Anheuser-Busch InBev (BUD), which fell 2.2% and 1.3% respectively.

The gainers from the UK were led by software firm Endava (DAVA) and biopharmaceutical company NuCana (NCNA), which advanced 5.7% and 3.3% respectively. They were followed by insurance company Prudential (PUK) and educational publisher Pearson (PSO), which increased 2.6% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 9.4% and 6.8% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and hospitality company InterContinental Hotels Group (IHG), which decreased 3% and 2.7% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment